相关实验视频

Updated: Jun 5, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

在使用多 (ADP-核糖) 聚合酶抑制剂用于前列腺癌的近期和未来发展

Francesca Zacchi¹, Wassim Abida², Emmanuel S Antonarakis³

¹Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust (AOUI) of Verona, Verona, Italy.

European urology oncology

|December 5, 2024

概括

多 (ADP-ribose) 聚合酶抑制剂 (PARPi) 显示在晚期前列腺癌 (PCa) 中具有DNA损伤修复基因变异的疗效,特别是BRCA1/2突变. 组合策略和改进的生物标志物是扩大PARPi在PCa治疗中的好处的关键.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
药理学药理学是指药理学的学科.

背景情况:

晚期前列腺癌 (PCa) 经常表现出DNA损伤修复基因改变.
聚 (ADP-ribose) 聚合酶抑制剂 (PARPi) 提高了合成杀伤性,在PCa中表现出有效性,具有同类重组修复 (HRR) 基因变异,包括BRCA1/2突变.

研究的目的:

审查PARPi在先进和早期阶段PCa的最新临床试验进展.
讨论患者选择和生物标志物识别,以提高PARPi的疗效.
探索PCa中PARPi的组合治疗策略.

主要方法:

对研究前列腺癌中PARPi的临床试验的综述.
对患者分层的生物标志物数据的分析.
综合疗法研究的检查.

主要成果:

两种PARPi (olaparib, rucaparib) 已被批准用于转移性抗割PCa,标志着第一个生物标志物指导的指示.
批准PARPi与雄激素受体通路抑制剂的组合.
贫血和疲劳是主要的不良事件;胃肠道毒性很常见,但可以控制.

结论:

在PCa中,PARPi具有HRR突变,特别是BRCA1/2变异的有效性.
对于组合疗法,需要进一步优化患者分层.
未来的研究应该集中在预测生物标志物,治疗和早期疾病设置上.

关键词:

临床试验中的临床试验.组合疗法是一种联合疗法.修复DNA损伤的修复尼拉帕里比比 (Niraparib) 是一个这就是Olaparib.聚 (ADP-ribose) 聚合酶抑制剂的多 (ADP-ribose) 抑制剂.前列腺癌是什么意思前列腺癌是什么意思鲁卡帕里巴里比 (鲁卡帕里巴里比)塔拉佐帕里比 (Talazoparib) 是一种可怕的药物.

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...